glp 1 winner Amanda Bonello interviews Sabina Hemmi, founder of Winner, about the Safe Drugs Act and state bills threatening compounded GLP-1 access, including semaglutide and tirzepatide, and what patients can do to protect mild dehydration GLP-1 and weight loss injections

Scenario 2 (delayed or limited approval): If cardiovascular safety concerns emerge (glucagon agonism theoretically increases heart rate and may elevate blood pressure in susceptible individuals) or gastrointestinal tolerability limits real-world adherence, retatrutide remains investigational

Similarly, reductions in tryptophan-metabolizing bacteria (e.g., Clostridium sporogenes and Bacteroides ) lower levels of indole-3aldehyde and other AHR ligands, impairing skin barrier repair and immune regulation

By reducing cytokine release and macrophage infiltration, GLP-1-RAs inhibit chronic inflammatory processes implicated in insulin resistance and cancer development

Get it wrong, and you could compromise the concentration, leading to skewed data and wasted resources

As such, ALCAR is considered a more potent alternative to L-Carnitine

Frequency and administration will vary based on individual needs and goals